Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-21.39	78.32	99.62
Graham Fair Price	250.19	17.99	5.14
PEG	-99.42	0.05	-7.82
Price/Book	-5.62	1.01	1.07
Price/Cash Flow	78.34	-50.67	-233.95
Prices/Earnings	-92.99	53.94	770.01
Price/Sales	-5.40	3.94	4.16
Price/FCF	78.34	-50.67	-233.95
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.05	0.04	0.04
Operating Margin	619.74	0.03	< 0.005
ROA	1188.26	< 0.005	< 0.005
ROE	< 0.005	< 0.005	1247.30
ROIC	< 0.005	< 0.005	1467.50
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.04	0.02	169.76
Dividends QOQ	-1.00	-1.00	-0.03
EBIT QOQ	-0.96	5.90	515.41
EPS QOQ	-0.98	11.87	1106.16
FCF QOQ	-1.15	-3.19	-176.85
Revenue QOQ	< 0.005	-0.04	368.42
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	47.52	51.46	8.30
Days Sales Outstanding (DSO)	38.10	50.04	31.33
Inventory Turnover	1.89	1.75	-7.66
Debt/Capitalization	0.30	0.32	6.08
Quick Ratio	1.59	1.26	-20.68
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	58.00	55.34	-4.59
Cash	21.19	18.97	-10.51
Capex	-1.16	-0.63	45.64
Free Cash Flow	-0.27	-1.11	-315.79
Revenue	14.98	14.26	-4.81
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.12	1.72	-18.94
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	25.38	22.33	-12.02
Naive Interpretation	Member

06 - Financial Health · Weak

Rating